Additive Effects of Dorzagliatin and Glucagon-Like Peptide 1 Receptor Agonism in a Novel Mouse Model of GCK-MODY and in Obese db/db Mice. - Salazar S; Delgadillo-Silva LF; Carapeto P; Kenfaoui MM; Dakessian K; Melhem R; Provencher-Girard A; Ostinelli G; Turgeon J; Kaci I; Migneault F; Huising MO; et al. (Diabetes, 2026)